160 related articles for article (PubMed ID: 18025258)
21. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
22. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth.
Ogawa Y; Suzuki T; Oikawa A; Hosono K; Kubo H; Amano H; Ito Y; Kitasato H; Hayashi I; Kato T; Sugimoto Y; Narumiya S; Watanabe M; Majima M
Biochem Biophys Res Commun; 2009 May; 382(4):720-5. PubMed ID: 19318087
[TBL] [Abstract][Full Text] [Related]
24. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.
Conejo-Garcia JR; Benencia F; Courreges MC; Kang E; Mohamed-Hadley A; Buckanovich RJ; Holtz DO; Jenkins A; Na H; Zhang L; Wagner DS; Katsaros D; Caroll R; Coukos G
Nat Med; 2004 Sep; 10(9):950-8. PubMed ID: 15334073
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of angiogenic factors in Ewing tumor xenografts by the combination of human interferon-alpha or interferon-beta with ifosfamide.
Sancéau J; Wietzerbin J
Ann N Y Acad Sci; 2004 Dec; 1030():170-8. PubMed ID: 15659795
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung.
Zhou Z; Stewart KS; Yu L; Kleinerman ES
Angiogenesis; 2011 May; 14(2):125-33. PubMed ID: 21184173
[TBL] [Abstract][Full Text] [Related]
27. Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.
van der Schaft DW; Hillen F; Pauwels P; Kirschmann DA; Castermans K; Egbrink MG; Tran MG; Sciot R; Hauben E; Hogendoorn PC; Delattre O; Maxwell PH; Hendrix MJ; Griffioen AW
Cancer Res; 2005 Dec; 65(24):11520-8. PubMed ID: 16357161
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
Mohamedali KA; Poblenz AT; Sikes CR; Navone NM; Thorpe PE; Darnay BG; Rosenblum MG
Cancer Res; 2006 Nov; 66(22):10919-28. PubMed ID: 17108129
[TBL] [Abstract][Full Text] [Related]
29. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
30. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels.
Reddy K; Zhou Z; Schadler K; Jia SF; Kleinerman ES
Mol Cancer Res; 2008 Jun; 6(6):929-36. PubMed ID: 18567797
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.
Ritter E; Perry A; Yu J; Wang T; Tang L; Bieberich E
Ann Surg; 2008 Feb; 247(2):310-4. PubMed ID: 18216538
[TBL] [Abstract][Full Text] [Related]
33. [Stem cells and connective-tissue tumors: Ewing's sarcoma].
Tirode F; Delattre O
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S33-4. PubMed ID: 18984293
[No Abstract] [Full Text] [Related]
34. Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice.
Ruan GR; Liu YR; Chen SS; Fu JY; Chang Y; Qin YZ; Li JL; Yu H; Wang H
Leuk Res; 2004 Jul; 28(7):763-9. PubMed ID: 15158098
[TBL] [Abstract][Full Text] [Related]
35. [Ewing's sarcoma (electron microscopy study)].
Litvinova LV; Solov'ev IuN
Arkh Patol; 1982; 44(2):9-16. PubMed ID: 7073515
[TBL] [Abstract][Full Text] [Related]
36. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcoma.
Kreuter M; Paulussen M; Boeckeler J; Gerss J; Buerger H; Liebscher C; Kessler T; Jurgens H; Berdel WE; Mesters RM
Eur J Cancer; 2006 Aug; 42(12):1904-11. PubMed ID: 16824746
[TBL] [Abstract][Full Text] [Related]
38. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F
Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985
[TBL] [Abstract][Full Text] [Related]
39. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
[TBL] [Abstract][Full Text] [Related]
40. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
